Top

Published in:

01-08-2014

Comparative effects of gastric bypass and sleeve gastrectomy on plasma osteopontin concentrations in humans

Authors: Andoni Lancha, Rafael Moncada, Víctor Valentí, Amaia Rodríguez, Victoria Catalán, Sara Becerril, Beatriz Ramírez, Leire Méndez-Giménez, María J. Gil, Fernando Rotellar, Secundino Fernández, Javier Salvador, Gema Frühbeck, Javier Gómez-Ambrosi

Published in: Surgical Endoscopy | Issue 8/2014

Abstract

Background

Bariatric surgery (BS) has proven to be an effective treatment for morbid obesity. Osteopontin (OPN) is a proinflammatory cytokine involved in the development of obesity. The aim of our study was to determine the effect of weight loss following BS on circulating levels of OPN in humans.

Methods

Body composition and circulating concentrations of OPN and markers of bone metabolism were determined in obese patients who underwent Roux-en-Y gastric bypass (RYGB; n = 40) or sleeve gastrectomy (SG; n = 11).

Results

Patients who underwent RYGB or SG showed decreased body weight (P < 0.001) and body fat percentage (P < 0.001) as well as lower insulin resistance. However, plasma OPN levels were significantly increased after RYGB (P < 0.001) but remained unchanged following SG (P = 0.152). Patients who underwent RYGB also showed significantly increased C-terminal telopeptide of type-I collagen (ICTP) (P < 0.01) and osteocalcin (P < 0.001) while bone mineral density tended to decrease (P = 0.086). Moreover, OPN concentrations were positively correlated with the bone resorption marker ICTP after surgery. On the other hand, patients who underwent SG showed significantly increased ICTP levels (P < 0.05), and the change in OPN was positively correlated with the change in ICTP and negatively with the change in vitamin D after surgery (P < 0.05).

Conclusions

RYGB increased circulating OPN levels, while they remained unaltered after SG. The increase in OPN levels after RYGB could be related to the increased bone resorption in relation to its well-known effects on bone of this malabsorptive procedure in comparison to the merely restrictive SG.

Swinburn BA, Sacks G, Hall KD, McPherson K, Finegood DT, Moodie ML, Gortmaker SL (2011) The global obesity pandemic: shaped by global drivers and local environments. Lancet 378:804–814PubMedCrossRef

Flegal KM, Carroll MD, Kit BK, Ogden CL (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 307:491–497PubMedCrossRef

Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, Moore SC, Tobias GS, Anton-Culver H, Freeman LB, Beeson WL, Clipp SL, English DR, Folsom AR, Freedman DM, Giles G, Hakansson N, Henderson KD, Hoffman-Bolton J, Hoppin JA, Koenig KL, Lee IM, Linet MS, Park Y, Pocobelli G, Schatzkin A, Sesso HD, Weiderpass E, Willcox BJ, Wolk A, Zeleniuch-Jacquotte A, Willett WC, Thun MJ (2010) Body-mass index and mortality among 1.46 million white adults. N Engl J Med 363:2211–2219PubMedCrossRef

Ashrafian H, le Roux CW, Darzi A, Athanasiou T (2008) Effects of bariatric surgery on cardiovascular function. Circulation 118:2091–2102PubMedCrossRef

Geloneze B, Geloneze SR, Chaim E, Hirsch FF, Felici AC, Lambert G, Tambascia MA, Pareja JC (2012) Metabolic surgery for non-obese type 2 diabetes: incretins, adipocytokines, and insulin secretion/resistance changes in a 1-year interventional clinical controlled study. Ann Surg 256:72–78PubMedCrossRef

Sjöström L (2013) Review of the key results from the Swedish Obese Subjects (SOS) trial: a prospective controlled intervention study of bariatric surgery. J Intern Med 273:219–234PubMedCrossRef

Pournaras DJ, le Roux CW (2013) Preventing type 2 diabetes, CVD, and mortality: surgical versus non-surgical weight loss strategies. Curr Atheroscler Rep 15:367PubMedCrossRef

Sjöström L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjöström CD, Sullivan M, Wedel H (2004) Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351:2683–2693PubMedCrossRef

Gómez-Ambrosi J, Pastor C, Salvador J, Silva C, Rotellar F, Gil MJ, Catalán V, Rodríguez A, Cienfuegos JA, Frühbeck G (2007) Influence of waist circumference on the metabolic risk associated with impaired fasting glucose: effect of weight loss after gastric bypass. Obes Surg 17:585–591PubMedCrossRef

10.

Scott WR, Batterham RL (2011) Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: understanding weight loss and improvements in type 2 diabetes after bariatric surgery. Am J Physiol Regul Integr Comp Physiol 301:R15–R27PubMedCrossRef

11.

Gould J, Ellsmere J, Fanelli R, Hutter M, Jones S, Pratt J, Schauer P, Schirmer B, Schwaitzberg S, Jones DB (2011) Panel report: best practices for the surgical treatment of obesity. Surg Endosc 25:1730–1740PubMedCrossRef

12.

Romero F, Nicolau J, Flores L, Casamitjana R, Ibarzabal A, Lacy A, Vidal J (2012) Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-En-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects. Surg Endosc 26:2231–2239PubMedCrossRef

13.

Peeters A, O’Brien PE, Laurie C, Anderson M, Wolfe R, Flum D, MacInnis RJ, English DR, Dixon J (2007) Substantial intentional weight loss and mortality in the severely obese. Ann Surg 246:1028–1033PubMedCrossRef

14.

Sjöstrom L, Narbro K, Sjöstrom CD, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B, Bengtsson C, Dahlgren S, Gummesson A, Jacobson P, Karlsson J, Lindroos AK, Lonroth H, Naslund I, Olbers T, Stenlof K, Torgerson J, Agren G, Carlsson LM (2007) Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357:741–752PubMedCrossRef

15.

Gómez-Ambrosi J, Catalán V, Ramírez B, Rodríguez A, Colina I, Silva C, Rotellar F, Mugueta C, Gil MJ, Cienfuegos JA, Salvador J, Frühbeck G (2007) Plasma osteopontin levels and expression in adipose tissue are increased in obesity. J Clin Endocrinol Metab 92:3719–3727PubMedCrossRef

16.

Gómez-Ambrosi J, Azcona C, Patiño-García A, Frühbeck G (2008) Serum amyloid A concentration is increased in obese children and adolescents. J Pediatr 153:71–75PubMedCrossRef

17.

Catalán V, Gómez-Ambrosi J, Rodríguez A, Salvador J, Frühbeck G (2009) Adipokines in the treatment of diabetes mellitus and obesity. Expert Opin Pharmacother 10:239–254PubMedCrossRef

18.

Catalán V, Gómez-Ambrosi J, Ramírez B, Rotellar F, Pastor C, Silva C, Rodríguez A, Gil MJ, Cienfuegos JA, Frühbeck G (2007) Proinflammatory cytokines in obesity: impact of type 2 diabetes mellitus and gastric bypass. Obes Surg 17:1464–1474PubMedCrossRef

19.

Forsythe LK, Wallace JM, Livingstone MB (2008) Obesity and inflammation: the effects of weight loss. Nutr Res Rev 21:117–133PubMedCrossRef

20.

Tziomalos K, Dimitroula HV, Katsiki N, Savopoulos C, Hatzitolios AI (2010) Effects of lifestyle measures, antiobesity agents, and bariatric surgery on serological markers of inflammation in obese patients. Mediat Inflamm 2010:364957CrossRef

21.

Catalán V, Gómez-Ambrosi J, Rodríguez A, Ramírez B, Rotellar F, Valentí V, Silva C, Gil MJ, Fernández-Real JM, Salvador J, Frühbeck G (2011) Increased levels of calprotectin in obesity are related to macrophage content: impact on inflammation and effect of weight loss. Mol Med 17:1157–1167PubMedCentralPubMedCrossRef

22.

Bertola A, Deveaux V, Bonnafous S, Rousseau D, Anty R, Wakkach A, Dahman M, Tordjman J, Clement K, McQuaid SE, Frayn KN, Huet PM, Gugenheim J, Lotersztajn S, Le Marchand-Brustel Y, Tran A, Gual P (2009) Elevated expression of osteopontin may be related to adipose tissue macrophage accumulation and liver steatosis in morbid obesity. Diabetes 58:125–133PubMedCentralPubMedCrossRef

23.

Wai PY, Kuo PC (2004) The role of osteopontin in tumor metastasis. J Surg Res 121:228–241PubMedCrossRef

24.

Towler DA, Bidder M, Latifi T, Coleman T, Semenkovich CF (1998) Diet-induced diabetes activates an osteogenic gene regulatory program in the aortas of low density lipoprotein receptor-deficient mice. J Biol Chem 273:30427–30434PubMedCrossRef

25.

Mazzali M, Kipari T, Ophascharoensuk V, Wesson JA, Johnson R, Hughes J (2002) Osteopontin—a molecule for all seasons. QJM 95:3–13PubMedCrossRef

26.

O’Regan A (2003) The role of osteopontin in lung disease. Cytokine Growth Factor Rev 14:479–488PubMedCrossRef

27.

Sahai A, Malladi P, Melin-Aldana H, Green RM, Whitington PF (2004) Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model. Am J Physiol Gastrointest Liver Physiol 287:G264–G273PubMedCrossRef

28.

Scatena M, Liaw L, Giachelli CM (2007) Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 27:2302–2309PubMedCrossRef

29.

Hurtado del Pozo CH, Calvo RM, Vesperinas-García G, Gómez-Ambrosi J, Frühbeck G, Rubio MA, Obregón MJ (2011) Expression profile in omental and subcutaneous adipose tissue from lean and obese subjects. Repression of lipolytic and lipogenic genes. Obes Surg 21:633–643CrossRef

30.

Riedl M, Vila G, Maier C, Handisurya A, Shakeri-Manesch S, Prager G, Wagner O, Kautzky-Willer A, Ludvik B, Clodi M, Luger A (2008) Plasma osteopontin increases after bariatric surgery and correlates with markers of bone turnover but not with insulin resistance. J Clin Endocrinol Metab 93:2307–2312PubMedCrossRef

31.

Schaller G, Aso Y, Schernthaner GH, Kopp HP, Inukai T, Kriwanek S, Schernthaner G (2009) Increase of osteopontin plasma concentrations after bariatric surgery independent from inflammation and insulin resistance. Obes Surg 19:351–356PubMedCrossRef

32.

Fried M, Yumuk V, Oppert JM, Scopinaro N, Torres AJ, Weiner R, Yashkov Y, Frühbeck G (2013) Interdisciplinary European guidelines on metabolic and bariatric surgery. Obes Facts 6:449–468PubMedCrossRef

33.

Gómez-Ambrosi J, Silva C, Galofré JC, Escalada J, Santos S, Gil MJ, Valentí V, Rotellar F, Ramírez B, Salvador J, Frühbeck G (2011) Body adiposity and type 2 diabetes: increased risk with a high body fat percentage even having a normal BMI. Obesity (Silver Spring) 19:1439–1444CrossRef

34.

Gómez-Ambrosi J, Silva C, Galofré JC, Escalada J, Santos S, Millán D, Vila N, Ibañez P, Gil MJ, Valentí V, Rotellar F, Ramírez B, Salvador J, Frühbeck G (2012) Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity. Int J Obes (Lond) 36:286–294CrossRef

35.

Gómez-Ambrosi J, Salvador J, Rotellar F, Silva C, Catalán V, Rodríguez A, Gil MJ, Frühbeck G (2006) Increased serum amyloid A concentrations in morbid obesity decrease after gastric bypass. Obes Surg 16:262–269PubMedCrossRef

36.

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419PubMedCrossRef

37.

Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85:2402–2410PubMedCrossRef

38.

Bal BS, Finelli FC, Shope TR, Koch TR (2012) Nutritional deficiencies after bariatric surgery. Nat Rev Endocrinol 8:544–556PubMedCrossRef

39.

Vilarrasa N, de Gordejuela AG, Gomez-Vaquero C, Pujol J, Elio I, San Jose P, Toro S, Casajoana A, Gomez JM (2013) Effect of bariatric surgery on bone mineral density: comparison of gastric bypass and sleeve gastrectomy. Obes Surg 23:2086–2091PubMedCrossRef

40.

Ruiz-Tovar J, Oller I, Priego P, Arroyo A, Calero A, Diez M, Zubiaga L, Calpena R (2013) Short- and mid-term changes in bone mineral density after laparoscopic sleeve gastrectomy. Obes Surg 23:861–866PubMedCrossRef

41.

Coates PS, Fernstrom JD, Fernstrom MH, Schauer PR, Greenspan SL (2004) Gastric bypass surgery for morbid obesity leads to an increase in bone turnover and a decrease in bone mass. J Clin Endocrinol Metab 89:1061–1065PubMedCrossRef

42.

Gómez JM, Vilarrasa N, Masdevall C, Pujol J, Solano E, Soler J, Elio I, Gallart L, Vendrell J (2009) Regulation of bone mineral density in morbidly obese women: a cross-sectional study in two cohorts before and after bypass surgery. Obes Surg 19:345–350PubMedCrossRef

43.

Okamoto N, Aruga S, Tomita K, Takeuchi T, Kitamura T (2007) Chronic acid ingestion promotes renal stone formation in rats treated with vitamin D3. Int J Urol 14:60–66PubMedCrossRef

44.

Phan O, Ivanovski O, Nikolov IG, Joki N, Maizel J, Louvet L, Chasseraud M, Nguyen-Khoa T, Lacour B, Drueke TB, Massy ZA (2008) Effect of oral calcium carbonate on aortic calcification in apolipoprotein E-deficient (apoE ^−/−) mice with chronic renal failure. Nephrol Dial Transplant 23:82–90PubMedCrossRef

45.

Stemmer K, Bielohuby M, Grayson BE, Begg DP, Chambers AP, Neff C, Woods SC, Erben RG, Tschop MH, Bidlingmaier M, Clemens TL, Seeley RJ (2013) Roux-en-Y gastric bypass surgery but not vertical sleeve gastrectomy decreases bone mass in male rats. Endocrinology 154:2015–2024PubMedCrossRef

46.

Canales BK, Reyes L, Reinhard MK, Khan SR, Goncalves CG, Meguid MM (2012) Renal glomerular and tubular injury after gastric bypass in obese rats. Nutrition 28:76–80PubMedCentralPubMedCrossRef

47.

Folli F, Sabowitz BN, Schwesinger W, Fanti P, Guardado-Mendoza R, Muscogiuri G (2012) Bariatric surgery and bone disease: from clinical perspective to molecular insights. Int J Obes (Lond) 36:1373–1379CrossRef

48.

Yu W, Cline M, Maxwell LG, Berrigan D, Rodriguez G, Warri A, Hilakivi-Clarke L (2010) Dietary vitamin D exposure prevents obesity-induced increase in endometrial cancer in Pten ^+/− mice. Cancer Prev Res (Phila) 3:1246–1258CrossRef

49.

Wang F, Jiang T, Tang C, Su Z, Zhang N, Li G (2011) Ghrelin reduces rat myocardial calcification induced by nicotine and vitamin D3 in vivo. Int J Mol Med 28:513–519PubMed

50.

Komorowski J, Jankiewicz-Wika J, Kolomecki K, Cywinski J, Piestrzeniewicz K, Swietoslawski J, Stepien H (2011) Systemic blood osteopontin, endostatin, and E-selectin concentrations after vertical banding surgery in severely obese adults. Cytokine 55:56–61PubMedCrossRef

51.

Frühbeck G, Diez Caballero A, Gil MJ (2004) Fundus functionality and ghrelin concentrations after bariatric surgery. N Engl J Med 350:308–309PubMedCrossRef

52.

Schindler K, Prager G, Ballaban T, Kretschmer S, Riener R, Buranyi B, Maier C, Luger A, Ludvik B (2004) Impact of laparoscopic adjustable gastric banding on plasma ghrelin, eating behaviour and body weight. Eur J Clin Invest 34:549–554PubMedCrossRef

53.

Foschi D, Corsi F, Colombo F, Vago T, Bevilaqua M, Rizzi A, Trabucchi E (2008) Different effects of vertical banded gastroplasty and Roux-en-Y gastric bypass on meal inhibition of ghrelin secretion in morbidly obese patients. J Invest Surg 21:77–81PubMedCrossRef

54.

Li GZ, Jiang W, Zhao J, Pan CS, Cao J, Tang CS, Chang L (2005) Ghrelin blunted vascular calcification in vivo and in vitro in rats. Regul Pept 129:167–176PubMedCrossRef

55.

Nomiyama T, Perez-Tilve D, Ogawa D, Gizard F, Zhao Y, Heywood EB, Jones KL, Kawamori R, Cassis LA, Tschop MH, Bruemmer D (2007) Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. J Clin Invest 117:2877–2888PubMedCentralPubMedCrossRef

56.

Kiefer FW, Zeyda M, Todoric J, Huber J, Geyeregger R, Weichhart T, Aszmann O, Ludvik B, Silberhumer GR, Prager G, Stulnig TM (2008) Osteopontin expression in human and murine obesity: extensive local up-regulation in adipose tissue but minimal systemic alterations. Endocrinology 149:1350–1357PubMedCrossRef

57.

Chapman J, Miles PD, Ofrecio JM, Neels JG, Yu JG, Resnik JL, Wilkes J, Talukdar S, Thapar D, Johnson K, Sears DD (2010) Osteopontin is required for the early onset of high fat diet-induced insulin resistance in mice. PLoS ONE 5:e13959PubMedCentralPubMedCrossRef

58.

Kiefer FW, Zeyda M, Gollinger K, Pfau B, Neuhofer A, Weichhart T, Saemann MD, Geyeregger R, Schlederer M, Kenner L, Stulnig TM (2010) Neutralization of osteopontin inhibits obesity-induced inflammation and insulin resistance. Diabetes 59:935–946PubMedCentralPubMedCrossRef

59.

Kiefer FW, Neschen S, Pfau B, Legerer B, Neuhofer A, Kahle M, Hrabe de Angelis M, Schlederer M, Mair M, Kenner L, Plutzky J, Zeyda M, Stulnig TM (2011) Osteopontin deficiency protects against obesity-induced hepatic steatosis and attenuates glucose production in mice. Diabetologia 54:2132–2142PubMedCentralPubMedCrossRef

60.

Lancha A, Frühbeck G, Gómez-Ambrosi J (2012) Peripheral signalling involved in energy homeostasis control. Nutr Res Rev 25:223–248PubMedCrossRef

Title: Comparative effects of gastric bypass and sleeve gastrectomy on plasma osteopontin concentrations in humans
Authors: Andoni Lancha
Rafael Moncada
Víctor Valentí
Amaia Rodríguez
Victoria Catalán
Sara Becerril
Beatriz Ramírez
Leire Méndez-Giménez
María J. Gil
Fernando Rotellar
Secundino Fernández
Javier Salvador
Gema Frühbeck
Javier Gómez-Ambrosi
Publication date: 01-08-2014
Publisher: Springer US
Published in: Surgical Endoscopy / Issue 8/2014
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI: https://doi.org/10.1007/s00464-014-3490-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Comparative effects of gastric bypass and sleeve gastrectomy on plasma osteopontin concentrations in humans

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 8/2014

The efficacy of single-dose postoperative intravenous dexamethasone for pain relief after endoscopic submucosal dissection for gastric neoplasm

SAGES guidelines for the introduction of new technology and techniques

Laparoscopic repair of perforated peptic ulcer: single-center results

Comparative evaluation of HD 2D/3D laparoscopic monitors and benchmarking to a theoretically ideal 3D pseudodisplay: even well-experienced laparoscopists perform better with 3D

Gender influence on long-term weight loss after three bariatric procedures: gastric banding is less effective in males in a retrospective analysis

Transvaginal specimen extraction versus conventional minilaparotomy after laparoscopic anterior resection for colorectal cancer: mid-term results of a case-matched study